ROCHESTER, Minn., Jan. 22 (UPI) -- Certain measles virus vaccine strain derivatives may prove an effective treatment for patients with advanced prostate cancer, U.S. researchers said.
LOS ANGELES, Feb. 1 (UPI) -- University of Southern California researchers have developed a vaccine that prevented cancer in 90 mice genetically predestined for prostate cancer.
SEATTLE, May 31 (UPI) -- Dendreon said Thursday the U.S. Food and Drug Administration has confirmed the data needed for approval of prostate cancer vaccine Provenge.
MADISON, Wis., Nov. 8 (UPI) -- U.S. scientists have discovered a specific biochemical pathway involved in the development of prostate cancer.
SOUTH SAN FRANCISCO, Calif., July 5 (UPI) -- Cell Genesys said Wednesday data from a phase 1/2 trial show its prostate cancer vaccine GVAX induces immune responses.
SEATTLE, Nov. 7 (UPI) -- The Food and Drug Administration has granted fast-track status to Dendreon Corp.'s Provenge to treat prostate cancer, the firm said Monday.
NEW YORK, Oct. 29 (UPI) -- In clinical trials, an experimental vaccine extended the lives of men with advanced prostate cancer, The New York Times reported Friday.
NEW ORLEANS, June 8 (UPI) -- Clinical trials of a French drug used to treat breast and lung cancers has shown it also extends the lives of prostate cancer patients.
WASHINGTON, June 24 (UPI) -- A new study indicates a drug used to fight baldness and enlarged prostates also increases protection against prostate cancer.
DURHAM, N.C., Jan. 30 (UPI) -- A new study in its early phase suggests a cancer vaccine made with prostate cancer patients' own cells is safe and effectively triggers an immune system attack on the tumor. Dr. Johannes Vieweg of Duke University Medical Center tested the experimental vac
